Bill

Bill > S1094


FL S1094

FL S1094
Practice of Pharmacy


summary

Introduced
12/02/2019
In Committee
12/13/2019
Crossed Over
Passed
Dead
03/19/2020

Introduced Session

2020 Regular Session

Bill Summary

Requiring certain licensed pharmacists to report specified information relating to public health to the Department of Health; requiring a pharmacist to complete additional training to be licensed as a consultant pharmacist; specifying criteria a pharmacist must meet to provide services under a collaborative pharmacy practice agreement; prohibiting collaborating physicians from delegating to pharmacists the authority to initiate or prescribe a controlled substance, etc.

AI Summary

This bill: 1. Requires certain licensed pharmacists to report specified public health information to the Department of Health. 2. Requires pharmacists to complete additional training to be licensed as consultant pharmacists. 3. Establishes criteria for pharmacists to provide services under a collaborative pharmacy practice agreement with a physician, including ordering and evaluating laboratory/clinical tests, conducting patient assessments, and modifying or discontinuing medications for chronic health conditions. 4. Prohibits physicians from delegating to pharmacists the authority to initiate or prescribe controlled substances under a collaborative agreement. 5. Requires pharmacists practicing under a collaborative agreement to complete additional continuing education on the relevant chronic conditions. The bill aims to expand the scope of pharmacy practice, particularly in the management of chronic health conditions, while maintaining oversight and collaboration with physicians.

Committee Categories

Budget and Finance, Health and Social Services

Sponsors (1)

Other Sponsors (2)

Appropriations (Senate), Health Policy (Senate)

Last Action

Laid on Table, refer to CS/CS/HB 599 (on 03/10/2020)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...